Cargando…

Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018–2020

BACKGROUND: Despite Rwanda’s progress toward HIV epidemic control, 16.2% of HIV-positive individuals are unaware of their HIV positive status. Tailoring the public health strategy could help reach these individuals with new HIV infection and achieve epidemic control. Recency testing is primarily for...

Descripción completa

Detalles Bibliográficos
Autores principales: Rwibasira, Gallican N., Malamba, Samuel S., Musengimana, Gentille, Nkunda, Richard C. M., Omolo, Jared, Remera, Eric, Masengesho, Vedaste, Mbonitegeka, Valens, Dzinamarira, Tafadzwa, Kayirangwa, Eugenie, Mugwaneza, Placidie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598012/
https://www.ncbi.nlm.nih.gov/pubmed/34788323
http://dx.doi.org/10.1371/journal.pone.0259708
_version_ 1784600719245967360
author Rwibasira, Gallican N.
Malamba, Samuel S.
Musengimana, Gentille
Nkunda, Richard C. M.
Omolo, Jared
Remera, Eric
Masengesho, Vedaste
Mbonitegeka, Valens
Dzinamarira, Tafadzwa
Kayirangwa, Eugenie
Mugwaneza, Placidie
author_facet Rwibasira, Gallican N.
Malamba, Samuel S.
Musengimana, Gentille
Nkunda, Richard C. M.
Omolo, Jared
Remera, Eric
Masengesho, Vedaste
Mbonitegeka, Valens
Dzinamarira, Tafadzwa
Kayirangwa, Eugenie
Mugwaneza, Placidie
author_sort Rwibasira, Gallican N.
collection PubMed
description BACKGROUND: Despite Rwanda’s progress toward HIV epidemic control, 16.2% of HIV-positive individuals are unaware of their HIV positive status. Tailoring the public health strategy could help reach these individuals with new HIV infection and achieve epidemic control. Recency testing is primarily for surveillance, monitoring, and evaluation but it’s not for diagnostic purposes. However, it’s important to know what proportion of the newly diagnosed are recent infections so that HIV prevention can be tailored to the profile of people who are recently infected. We therefore used available national data to characterize individuals with recent HIV infection in Rwanda to inform the epidemic response. METHODS: We included all national-level data for recency testing reported from October 2018 to June 2020. Eligible participants were adults (aged ≥15 years) who had a new HIV diagnosis, who self-reported being antiretroviral therapy (ART) naïve, and who had consented to recency testing. Numbers and proportions of recent HIV infections were estimated, and precision around these estimates was calculated with 95% confidence intervals (CI). Logistic regression was used to assess factors associated with being recently (within 12 months) infected with HIV. RESULTS: Of 7,785 eligible individuals with a new HIV-positive diagnosis, 475 (6.1%) met the criteria for RITA recent infection. The proportion of RITA recent infections among individuals with newly identified HIV was high among those aged 15–24 years (9.6%) and in men aged ≥65 years (10.3%) compared to other age groups; and were higher among women (6.7%) than men (5.1%). Of all recent cases, 68.8% were women, and 72.2% were aged 15–34 years. The Northern province had the fewest individuals with newly diagnosed HIV but had the highest proportion of recent infections (10.0%) compared to other provinces. Recent infections decreased by 19.6% per unit change in time (measured in months). Patients aged ≥25 years were less likely to have recent infection than those aged 15–24 years with those aged 35–49 years being the least likely to have recent infection compared to those aged 15–24 years (adjusted odds ratio [aOR], 0.415 [95% CI: 0.316–0.544]). CONCLUSION: Public health surveillance targeting the areas and the identified groups with high risk of recent infection could help improve outcomes.
format Online
Article
Text
id pubmed-8598012
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-85980122021-11-18 Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018–2020 Rwibasira, Gallican N. Malamba, Samuel S. Musengimana, Gentille Nkunda, Richard C. M. Omolo, Jared Remera, Eric Masengesho, Vedaste Mbonitegeka, Valens Dzinamarira, Tafadzwa Kayirangwa, Eugenie Mugwaneza, Placidie PLoS One Research Article BACKGROUND: Despite Rwanda’s progress toward HIV epidemic control, 16.2% of HIV-positive individuals are unaware of their HIV positive status. Tailoring the public health strategy could help reach these individuals with new HIV infection and achieve epidemic control. Recency testing is primarily for surveillance, monitoring, and evaluation but it’s not for diagnostic purposes. However, it’s important to know what proportion of the newly diagnosed are recent infections so that HIV prevention can be tailored to the profile of people who are recently infected. We therefore used available national data to characterize individuals with recent HIV infection in Rwanda to inform the epidemic response. METHODS: We included all national-level data for recency testing reported from October 2018 to June 2020. Eligible participants were adults (aged ≥15 years) who had a new HIV diagnosis, who self-reported being antiretroviral therapy (ART) naïve, and who had consented to recency testing. Numbers and proportions of recent HIV infections were estimated, and precision around these estimates was calculated with 95% confidence intervals (CI). Logistic regression was used to assess factors associated with being recently (within 12 months) infected with HIV. RESULTS: Of 7,785 eligible individuals with a new HIV-positive diagnosis, 475 (6.1%) met the criteria for RITA recent infection. The proportion of RITA recent infections among individuals with newly identified HIV was high among those aged 15–24 years (9.6%) and in men aged ≥65 years (10.3%) compared to other age groups; and were higher among women (6.7%) than men (5.1%). Of all recent cases, 68.8% were women, and 72.2% were aged 15–34 years. The Northern province had the fewest individuals with newly diagnosed HIV but had the highest proportion of recent infections (10.0%) compared to other provinces. Recent infections decreased by 19.6% per unit change in time (measured in months). Patients aged ≥25 years were less likely to have recent infection than those aged 15–24 years with those aged 35–49 years being the least likely to have recent infection compared to those aged 15–24 years (adjusted odds ratio [aOR], 0.415 [95% CI: 0.316–0.544]). CONCLUSION: Public health surveillance targeting the areas and the identified groups with high risk of recent infection could help improve outcomes. Public Library of Science 2021-11-17 /pmc/articles/PMC8598012/ /pubmed/34788323 http://dx.doi.org/10.1371/journal.pone.0259708 Text en © 2021 Rwibasira et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rwibasira, Gallican N.
Malamba, Samuel S.
Musengimana, Gentille
Nkunda, Richard C. M.
Omolo, Jared
Remera, Eric
Masengesho, Vedaste
Mbonitegeka, Valens
Dzinamarira, Tafadzwa
Kayirangwa, Eugenie
Mugwaneza, Placidie
Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018–2020
title Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018–2020
title_full Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018–2020
title_fullStr Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018–2020
title_full_unstemmed Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018–2020
title_short Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018–2020
title_sort recent infections among individuals with a new hiv diagnosis in rwanda, 2018–2020
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598012/
https://www.ncbi.nlm.nih.gov/pubmed/34788323
http://dx.doi.org/10.1371/journal.pone.0259708
work_keys_str_mv AT rwibasiragallicann recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT malambasamuels recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT musengimanagentille recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT nkundarichardcm recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT omolojared recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT remeraeric recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT masengeshovedaste recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT mbonitegekavalens recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT dzinamariratafadzwa recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT kayirangwaeugenie recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020
AT mugwanezaplacidie recentinfectionsamongindividualswithanewhivdiagnosisinrwanda20182020